Thyroid dysfunction induced by nivolumab: searching for disease patterns and outcomes

ConclusionsTD induced by nivolumab is a common and heterogeneous irAE. Thyrotoxicosis develops earlier than hypothyroidism. A pattern consistent with a transient thyroiditis followed by hypothyroidism was observed in one-third of patients. Our results suggest that patients with NSCLC and nivolumab-induced TD might have better survival.
Source: Endocrine - Category: Endocrinology Source Type: research